Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 1
1997 2
1998 1
1999 3
2000 3
2001 1
2002 1
2003 1
2004 2
2005 2
2006 5
2007 3
2008 4
2009 1
2010 1
2011 3
2012 3
2013 2
2014 6
2015 2
2016 8
2017 10
2018 7
2019 8
2020 7
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Response.
Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Bledsoe TJ, et al. Among authors: burtness ba. J Natl Cancer Inst. 2018 Apr 1;110(4):433-434. doi: 10.1093/jnci/djx230. J Natl Cancer Inst. 2018. PMID: 29121329 No abstract available.
Head and neck cancers.
Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network. Pfister DG, et al. Among authors: burtness ba. J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. doi: 10.6004/jnccn.2011.0053. J Natl Compr Canc Netw. 2011. PMID: 21636536 Review. No abstract available.
High Dose Cisplatin: Still the One?
Husain ZA, Burtness BA. Husain ZA, et al. Among authors: burtness ba. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):615-616. doi: 10.1016/j.ijrobp.2019.09.026. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589986 No abstract available.
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.
Kann BH, Likitlersuang J, Bontempi D, Ye Z, Aneja S, Bakst R, Kelly HR, Juliano AF, Payabvash S, Guenette JP, Uppaluri R, Margalit DN, Schoenfeld JD, Tishler RB, Haddad R, Aerts HJWL, Garcia JJ, Flamand Y, Subramaniam RM, Burtness BA, Ferris RL. Kann BH, et al. Among authors: burtness ba. Lancet Digit Health. 2023 Jun;5(6):e360-e369. doi: 10.1016/S2589-7500(23)00046-8. Epub 2023 Apr 21. Lancet Digit Health. 2023. PMID: 37087370 Free PMC article. Clinical Trial.
86 results